St. Jude receives FDA approval for Cardiac Ablation Generator and Therapy catheters

New York, Dec. 1 - St. Jude Medical, Inc. said the Food and Drug Administration approved its IBI-1500T6 Cardiac Ablation Generator and Therapy electrophysiology catheters.

The St. Paul, Minn., medical device company launched the product to the market.

The FDA's decision expands the company's therapeutic electrophysiology portfolio with a new high-power, state-of-the-art ablation system, St. Jude said in a news release.

Ablation procedures are common in the treatment of cardiac arrhythmias, which affect approximately 5.3% of the U.S. adult population, or over 14 million people. Non-surgical ablation therapy is often recommended to "disconnect" or "isolate" the pathway of these abnormal rhythms, which, if left untreated, can lead to stroke or heart failure, the company said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.